Unmet needs in brain cancers and advances in drug discovery
August 27, 2025
News & Publications
In The News
5 Biotechs Taking the Pipline-in-a-Product Approach to Drug Development
August 20, 2025
Appointments and advancements for Aug. 13, 2025
August 13, 2025
Beware these 5 signs of a ‘highly invasive’ brain cancer
August 11, 2025
New York Post – Woman Beats Deadly Brain Cancer
August 6, 2025
Press Releases
Donna Rill New Hire
August 12, 2025
Phase 2 GBM Trial First Patient
July 22, 2025
Diakonos Oncology Presents Promising Phase I Results of Dubodencel (DOC1021) at the ASCO 2025 Annual Meeting
June 2, 2025
Diakonos Oncology Closes $20M financing to accelerate Phase 2 Glioblastoma Clinical Development Program
May 30, 2025
Diakonos Oncology Presents Phase I Analysis of DOC1021 at the 2025 American Academy of Neurology Annual Meeting
April 9, 2025
Company Presentations
Diakonos Oncology Presents Promising Phase I Results of Dubodencel (DOC1021) at the ASCO 2025 Annual Meeting
June 2, 2025
Diakonos Oncology Presents Phase I Analysis of DOC1021 at the 2025 American Academy of Neurology Annual Meeting
April 9, 2025
2025 Spring Symposium hosted by the William T. Shearer Center for Human Immunobiology
March 7, 2025
6th Annual Glioblastoma Drug Development Summit
February 19, 2025
SNO 2024 Presentation: DOC1021 Cell-Based Vaccination as Adjuvant Therapy for Glioblastoma: Phase I Clinical Trial Analysis
November 22, 2024
Publications
Science Translational Medicine: A Unique Subset of Cytotoxic Effector Memory T-cells Enhances CAR T-cell Function against Pancreatic Ductal Adenocarcinoma. Konduri V, Joseph S, Byrd TT, et al.
May 5, 2022
FASEB Journal: MHC class I and II peptide homology regulates the cellular immune response. FASEB. Halpert MM, Konduri V, Liang D, et al.
April 16, 2020
Cancer Gene Therapy: Dendritic cell vaccination plus low-dose Doxorubicin for the treatment of spontaneous canine hemangiosarcoma. Konduri V*, Halpert MM*, et al. Cancer Gene Therapy.
January 23, 2019
Frontiers in Immunology: AIMp1 Potentiates TH1 polarization and is critical for effective antitumor and antiviral immunity. Liang D, Tian L, You R, et al.
January 15, 2018
OncoImmunology: Chemo-immunotherapy mediates durable cure of orthotopic KrasG12D/p53-/- pancreatic ductal adenocarcinoma. Oncoimmunology. Konduri V, Li D, Halpert MM, et al.
July 22, 2016
Connect with us on social
